Hep B Vaccine: The Centers for Disease Control and Prevention's vaccine advisory panel voted Friday to change the recommendation for when children should get their first dose of the hepatitis B vaccine. Instead of a first dose within 24 hours of birth — as the CDC has advised for more than 30 years, which is the panel voted to recommend delaying it until a child is 2 months old for children born to mothers who test negative for the virus.

The advisory committee has now endorsed a plan that allows families of infants born to hepatitis B negative mothers to decide, with their doctor, when the birth dose should be given. The vote was 8 to 2 in favour of shifting to case-by-case discussions rather than a universal early dose.

Hep B Vaccine: CDC Panel Recommends Delaying Birth Dose Of Hepatitis B Vaccine

A number of medical bodies, including the American Academy of Pediatrics, opposed the proposal. They cautioned that delaying this first shot exposes infants to unnecessary danger and pointed to extensive evidence confirming the vaccine’s long record of safety and effectiveness.

The vote came during the second day of the committee’s December session, after confusion on Thursday forced the group to postpone making a decision.

All members of the panel were appointed by Health and Human Services Secretary Robert F. Kennedy Jr. The meeting opened with the reading of the draft language, followed by extended debate among committee members and invited specialists. Restef Levi, a panel member with a mathematics background and no clinical training, spoke forcefully against the long-standing policy and made incorrect claims about how the vaccine had been evaluated.

Senior paediatric experts, including Dr Cody Meissner, a former member of both the FDA vaccines panel and ACIP, and committee member Dr Joseph Hibbeln, continued to raise objections throughout the discussion. Hibbeln pointed out that this was the fourth iteration of the wording presented to them in a span of roughly four days and said that no solid scientific evidence had been offered to justify changing the recommendation. Meissner argued that the current guidance already permits parental choice and said revising the language would do more harm than good.

Hep B Vaccine: What Is It About?

Hepatitis B is an incurable viral infection that can lead to chronic liver disease, cancer and early death. The United States has recommended the newborn hepatitis B dose since 1991. Since then, infections in infants and children have dropped by 99 per cent.

ACIP’s recommendations now move to the CDC director for a final decision. States ultimately determine their own vaccination rules, though most follow federal guidance. Insurance coverage may also shift if the recommendation changes, because private insurers rely heavily on ACIP decisions to determine what must be covered.

The newborn dose has become a focal point for vaccine critics, including Kennedy, who wrongly suggested earlier this year that the shot might be linked to autism. Studies have repeatedly shown the birth dose is safe. Research has found no higher risk of infant death, fever, sepsis, multiple sclerosis or autoimmune conditions. Severe adverse reactions remain rare, and there is no evidence that delaying the dose offers any safety advantage.

Hepatitis B: A Contentious 2-day Meeting

Following Friday’s vote, the committee was scheduled to move on to childhood vaccine schedules and vaccine ingredients. No additional votes were on the agenda.

The meeting opened Thursday morning, with the hepatitis B vote originally planned for that afternoon. Members reviewed data on acute and chronic hepatitis B rates, transmission patterns and vaccine safety.

Meissner criticised several of the presentations, including one that suggested limited safety information for the newborn dose.

Dr Jason Goldman, who represents the American College of Physicians on the committee, called the session “completely inappropriate” and said the group was wasting public resources by failing to hold a rigorous scientific debate. He also reminded the panel that the newborn dose has never been compulsory and that parents already make decisions in consultation with their child’s doctor.

The vote was postponed after members said they had been shown multiple shifting versions of the voting questions and could not see the final text due to a technical glitch. Without printed copies available, some members said they were unclear on how many questions they were expected to vote on. Hibbeln remarked that the committee was being asked to consider “a moving target.”

Similar disorder occurred at ACIP’s September meeting, when members appeared confused about what they were voting on. They initially rejected funding for a combined measles-mumps-rubella-varicella vaccine for toddlers, then reversed themselves minutes later, and then changed direction again the following day.

Hep B Vaccine: Why Are Newborns Vaccinated For Hepatitis B?

Infants who contract hepatitis B at birth or during their first year face a ninety per cent likelihood of developing chronic infection, which can lead to cirrhosis, liver failure and liver cancer. About a quarter of those who develop long-term infection die early from related complications.

Because the virus spreads through blood and body fluids and can survive on surfaces, many schools and childcare centres require children to be vaccinated.

The American Academy of Pediatrics stresses the importance of administering the birth dose as early as possible. Dr Sean O’Leary, chair of the AAP Committee on Infectious Diseases and an assistant professor at the University of Colorado School of Medicine, told CBS News before the meeting that the vaccine has one of the strongest safety records in paediatrics. He said it remains one of the most dependable tools for preventing severe liver disease and cancer in adulthood.

Sick days are again piling up with a respiratory disease, not COVID-19 or the flu. This disease is most likely the one Americans have not heard of. This is HMPV or human metapneumovirus. Doctors have asked people to stay vigilant as seasonal flu virus could lead to pneumonia and bronchitis, and it is spreading in California wastewater and around the country. However, as per public health officials, there is nothing to get worried at this point.

As per the public database WasterwaterScan Dashboard, high levels of HMPV were detected across Northern California cities. The highest levels were reported in Redwood City, whereas elevated levels were found in San Francisco Bay Area and Napa's Wine Country. What's more dangerous is that this virus is without a vaccine.

The good news is that in other parts of country HMPV remains lower. However, the Centers for Disease Control and Prevention (CDC) noted that data from October 2025 shows the cases are trending up, especially during winter and spring.

Dr. Matthew Binnicker, director of the Clinical Virology Laboratory at Mayo Clinic, as reported by The Independent said, "In the late winter, early spring, it can account for five percent to 10 percent of all the respiratory infections that we diagnose in the United States. So it's definitely out there." Experts explain that other viruses like HMPV or influenza get a chance when COVID is quieter.

Read: HMPV Virus Cases Surging In California, New Jersey: Is It Dangerous?

Virus Without A Vaccine: What Is HMPV?

HMPV was first discovered in 2001 and is part of the Pneumoviridae family along with the Respiratory syncytial virus (RSV).

HMPV most likely spreads from an infected person to others through:

• the air by coughing and sneezing
• close personal contact, such as touching or shaking hands
• touching objects or surfaces that have the viruses on them, then touching the mouth, nose, or eyes

In the US, HMPV circulates in predictable patterns each year, typically beginning in winter and lasting through spring.

The usually self-limiting and mild symptoms typically last 4 to 5 days. These include:

• cough
• fever
• nasal congestion
• shortness of breath

People at risk include:

• elderly people
• children
• people with comorbidities

"The HMPV is not deadly, and there is no evidence of mortality or a severe transmission rate," former Indian Council of Medical Research (ICMR) scientist, Dr. Raman Gangakhedkar, told IANS, during the virus's outbreak in India in 2025.

“The virus may cause pneumonitis-like illness, but the mortality rates are almost unknown so far. HMPV has a global prevalence of about 4 per cent,” he added.

While no vaccine or treatment can prevent HMPV infection, to avoid the infection, individuals must:

Practice good hygiene and cover your mouth and nose with a tissue when coughing or sneezing, or use your elbow, not your hands, for it. And wash your hands properly, especially in healthcare settings.

Why Are People Hearing About The Virus Without Vaccine Now?

The reason people have not heard about it before is because its symptoms are nearly indistinguishable from other respiratory infections, so often it could go undiagnosed. Furthermore, earlier the COVID cases and influenza cases sparked up, which deviated the attention from HMPV. Now, with the season gone, and increased awareness around respiratory illnesses, greater attention to viruses like HMPV is also paid.

One in seven Indians, or over 14 percent of the population, suffers from some form of mental health disorder. Amid an increasing treatment gap -- up to 90 percent -- seen in several states, especially in North India, the government today reiterated the plan of launching a second National Institute of Mental Health and Neurosciences (NIMHANS) in the northern states.

NIMHANS-2 was first announced by Finance Minister Nirmala Sitharaman during the Union Budget 2026-27, to deliver specialized care for mental health and neurological disorders in north India.

Health experts and policymakers, as part of the government-led Post-Budget Webinar series, highlighted the growing burden of mental and neurological disorders in India and also stressed the urgent need to strengthen institutional capacity to meet emerging healthcare demands.

"One in seven Indians is affected by mental health disorders, while several states continue to face a treatment gap ranging from 70 to 90 percent," the experts said.

Noting that Non-Communicable Diseases (NCDs) account for over 60 percent of deaths in the country, they added that "neurological and mental health conditions are among the leading contributors to disability-adjusted life years (DALYs)," among the citizens.

Need For Tertiary Neuro-psychiatric Care

To address these, the experts called for ramping up tertiary mental health institutions and expanding specialized services.

The session, moderated by Vijay Nehra, Joint Secretary, Ministry of Health and Family Welfare, highlighted that North India currently lacks adequate tertiary neuro-psychiatric care facilities. These include areas such as:

• advanced neuroimaging,
• neurocritical care,
• specialized neurological services

Further, making a virtual address at the Post-Budget Webinar, Union Health Minister JP Nadda also highlighted the government’s focus on strengthening mental healthcare services in the country.

"NIMHANS-2 will be established in North India to expand advanced clinical care, training, and research," Nadda said.

"In addition, the Central Institute of Psychiatry, Ranchi, and the Lokopriya Gopinath Bordoloi Regional Institute of Mental Health, Tezpur, will be upgraded as regional apex institutions to strengthen mental healthcare services in the eastern and north-eastern regions," he added.

Meanwhile, the experts also stressed the need to improve services in underserved and geographically remote regions, including the northeastern states, through better infrastructure, capacity building, and targeted deployment of trained mental health professionals.

They also discussed strategies for expanding advanced neuro-psychiatric care and reinforcing India’s overall mental healthcare ecosystem. They proposed:

• Adopting a hub-and-spoke model supported by digital health platforms

This would allow tertiary institutions and centers of excellence to provide technical guidance, specialist consultations, and clinical support to district hospitals and community-level health facilities.

"Such a model would strengthen referral pathways and ensure that specialized mental health services are accessible to people even in remote and rural areas," the experts said.

• Integrating services under Tele-MANAS

Both existing and upcoming campuses of NIMHANS must be integrated , as this will enable a robust nationwide tele-mental health network that ensures

• timely counselling,
• psychological support,
• specialist consultations

• Digital follow-up systems

The experts called for the seamless integration of healthcare facilities, aligned with the vision of the Ayushman Bharat Digital Mission and the ABHA ID ecosystem. This, they said, will

• enable continuity of care,
• Improve monitoring of patients,
• Lead to better clinical outcomes

• A national Brain-Mind Cloud Network

The Network proposed under the National Health Mission would connect premier institutions such as All India Institute of Medical Sciences (AIIMS), state medical colleges, and primary healthcare centers through a digitally integrated platform.

It could also facilitate

• unified mental health records,
• AI-based screening tools,
• data-driven clinical decision support systems,
• tele-neuro-psychiatric hubs at regional centers.

California and New Jersey in the US are seeing an uptick in cases of human metapneumovirus (HMPV) -- a virus with no vaccine or treatment.

According to the US Centers for Disease Control and Prevention (CDC), HMPV can cause upper and lower respiratory disease. There is currently no vaccine to prevent it, and no specific antiviral therapy to treat it.

"Most people will recover on their own," the agency noted, but advised people who get sick to drink plenty of liquids, stay home, and rest.

As per the CDC's respiratory dashboard, the cases of HMPV steadily ticked up since November 2025. It accounted for over 5 percent of positive tests the week of February 14 through February 21.

While HMPV is not a "new" virus, having first been discovered in 2001, cases haven't spiked to this level in the US since an outbreak in April 2025, USA Today reported.

The New Jersey Respiratory Surveillance Report cited that about 4 percent of residents in the state are testing positive for HMPV. The HMPV cases, accompanied by RSV, COVID, and flu cases, are surging, increasing the number of people seeking emergency medical care.

As per the public database, WastewaterScan Dashboard, HMPV is rampant in Northern California -- specifically San Francisco, Marin, Vallejo, Napa, Novato, Santa Rosa, Sacramento, and Davis, the Independent UK reported.

What Is HMPV? Is It Dangerous?

HMPV was first discovered in 2001 and is part of the Pneumoviridae family along with the Respiratory syncytial virus (RSV).

HMPV most likely spreads from an infected person to others through:

• the air by coughing and sneezing
• close personal contact, such as touching or shaking hands
• touching objects or surfaces that have the viruses on them, then touching the mouth, nose, or eyes

In the US, HMPV circulates in predictable patterns each year, typically beginning in winter and lasting through spring.

The usually self-limiting and mild symptoms typically last 4 to 5 days. These include:

• cough,
• fever,
• nasal congestion,
• shortness of breath

People at risk include:

• elderly people,
• children,
• people with comorbidities

"The HMPV is not deadly, and there is no evidence of mortality or a severe transmission rate," former Indian Council of Medical Research (ICMR) scientist, Dr. Raman Gangakhedkar, told IANS, during the virus's outbreak in India in 2025.

“The virus may cause pneumonitis-like illness, but the mortality rates are almost unknown so far. HMPV has a global prevalence of about 4 per cent,” he added.

While no vaccine or treatment can prevent HMPV infection, to avoid the infection, individuals must:

Practice good hygiene and cover your mouth and nose with a tissue when coughing or sneezing, or use your elbow, not your hands, for it. And wash your hands properly, especially in healthcare settings.